Letter: Long-term side effects of azathioprine. 1974

M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 1976, Psychiatria polska,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 1975, Acta dermato-venereologica,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 1982, Annals of the rheumatic diseases,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
December 1984, Zeitschrift fur Hautkrankheiten,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
February 1971, Lancet (London, England),
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
June 1981, La Nouvelle presse medicale,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 2016, Expert opinion on drug safety,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 1970, Respiration; international review of thoracic diseases,
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
April 1999, Deutsche medizinische Wochenschrift (1946),
M B Urowitz, and D A Gordon, and H A Smythe, and W Pruzanski, and M A Ogryzlo
January 2005, Psychosomatic medicine,
Copied contents to your clipboard!